Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Oct 5.
Published in final edited form as: Angew Chem Int Ed Engl. 2015 Aug 21;54(41):12053–12057. doi: 10.1002/anie.201506038

A Highly Selective Mitochondria-Targeting Fluorescent K+ Sensor**

Xiangxing Kong a,, Fengyu Su a,, Liqiang Zhang a,, Jordan Yaron a, Fred Lee a, Zhengwei Shi a, Yanqing Tian a,b,*, Deirdre R Meldrum a,*
PMCID: PMC4815426  NIHMSID: NIHMS768887  PMID: 26302172

Abstract

Regulation of intracellular potassium (K+) concentration plays a key role in metabolic processes. So far only a few intracellular K+ sensors have been developed. We report here a highly selective fluorescent K+ sensor, KS6, synthesized for monitoring K+ ion dynamics in mitochondria by coupling triphenylphosphonium, borondipyrromethene (BODIPY), and triazacryptand (TAC). KS6 possesses good response to K+ in the range of 30–500 mM, large dynamic range (Fmax/F0: ~130), high brightness (ϕf: 14.4% at 150 mM of K+) and insensitivity to pH (5.5–9.0) and other metal ions under physiological conditions. Colocalization test of KS6 with MitoTracker Green confirmed its predominant localization in mitochondria of HeLa and U87MG cells. K+ efflux/influx in the mitochondria was observed in HeLa and U87MG cells upon stimulation with ionophores, nigericin or ionomycin. Therefore, KS6 is a highly selective semi-quantitative K+ sensor suitable for the study of mitochondrial potassium.

Keywords: fluorescent probes, ion channel, potassium efflux, BODIPY, mitochondrial targeting potassium sensor

Graphical abstract

graphic file with name nihms768887u1.jpg

Mitochondrial K+ sensing: An intracellular mitochondria-specific K+ sensor, KS6, possessing a response range of K+ (30–500mM), a sensitive fluorescence enhancement (Fmax/F0: ~130), high brightness (ϕf: 14.4% at 150 mM of K+) and insensitivity to pH (5.5–9.0) and other metal ions under physiological conditions, was synthesized and tested in cell imaging. We believe KS6 is the first sensor for monitoring K+ ion change in mitochondria.


Potassium channels (KCh) are a class of transmembrane proteins with about 90 human genes coding for the principle subunits.[1] They involved in many physiological functions, such as cell proliferation, growth, apoptosis.[2] By opening or blocking KCh and thus adjusting the K+ concentration in cellular organelles, the cell can control its membrane potential, contribute to cardiac action potentials and neurotransmitter release, and affect many critical biological functions.[3] Recent research found that KCh is a potential pharmacological target in cancer, autoimmune disease, cardioprotection, and diabetes.[4] Typical research tools for KCh study include: 1) patch-clamp technique,[5] 2) fluxOR assay method using Tl+ ion and corresponding fluorescent probes,[6] and 3) Rb+ ion method.[7] These methods are well-developed in high throughput screening of drugs with certain type of KCh, but have limitations in understanding the relationship in a multi-factor cellular singaling pathway. Due to the lack of fluorescent potassium sensors, most research on KCh uses indirect experimental methods, leaving lots of uncertainty in the research conclusion.[8] Recent research demonstrated that K+ flux through the inner mitochondrial membrane had a significant effect in insulin secretion,[9] inflammasome formation,[10] and cell apoptosis.[11] Development of a mitochondria-targeting K+ sensor is critical in investigation of the K+-related mitochondrial signaling, anslysis of single cell metabolism and screening of new drugs.[12]

An ideal intracellular K+ sensor should have a large dynamic range compatible with the intracellular concentration of K+ (130 to 460 mM in different cell compartments[13]), and insensitivity to competing Na+ (5~15 mM in intracellular fluid; ~145 mM in extracellular fluid), pH, and other metal ions at physiological concentrations.[14] The best-known K+ sensors for molecular biology study, K+-binding benzofuran isophthalate (PBFI) and its cell permeable form bis(acetyloxymethyl) esterized PBFI (PBFI-AM) suffer from poor selectivity against Na+.[15] In 2003, He et al. discovered a fluorescent extracellular K+ sensor based on a highly selective triazacryptand (TAC) ligand, which features excellent selective response to K+ over Na+.[16] More recently, Verkman group[17] and our group[18] have respectively developed several fluorescent K+ sensors based on TAC ligand. By linking TAC to different positions of BODIPY, two different K+ ion sensors were reported.[17a, 19] The fluorescent K+ ion sensor based on 3-styrylated BODIPY by Hirata et al. demonstrated large apparent disassociation constant Kd (53 mM) from the spectroscopic data obtained in a mixture solution of HEPES (pH = 7.0)/MeCN (60/40); no in vivo cell imaging is available. As far as we know, these sensors are unsuitable for mitochondrial K+ sensing.

We report here a mitochondria-targeting K+ sensor by attaching a lipophilic triphenylphosphonium cation (TPP+) to 3-styrylated BODIPY, which contains K+-binding ligand TAC. TPP+ has been used as mitochondria-targeting moiety, due to its accumulation in the mitochondrial matrix.[20] Scheme 1 shows the synthetic route of the KS6 sensor. [6-(4-formylphenoxy)hexyl]triphenylphosphonium bromide (2) was prepared by reaction of 6-bromohexyloxybenzo-aldehyde with PPh3 in ethanol. The TPP+-containing BODIPY (3) was synthesized by reaction of 2 with 2,4-dimethylpyrrole catalyzed by trace amount of trifluoroacetic acid in anhydrous dichloromethane, followed by oxidization with p-chloranil and treatment with BF3·OEt2 and triethylamine. KS6 was obtained by condensation of 3 with TAC-CHO in benzene using piperidinium acetate as catalyst. The structure of the KS6 and intermediate 3 were characterized by 1H NMR and high resolution mass spectra (see Supporting Information). KS6 is soluble in organic solvents, such as DMSO, CH2Cl2, chloroform, etc., but insoluble in water.

Scheme 1.

Scheme 1

Synthetic route of KS6 and its response to K+.

To avoid using any organic solvent in KS6 titration, we dispersed KS6 (1.0 mM in DMSO) into three aqueous solutions (pH 7.4; Tris/HCl buffer: 5 mM; KS6: 5 μM) containing different surfactants: sodium dodecylsulfate (SDS), Pluronic F127 and centrimonium bromide (CTAB) with the surfactant concentrations below their critical micelle concentrations. Adding KCl stock solution (4.0 M) into KS6 in SDS solution caused a white precipitation, making it improper for titration. For KS6 in Pluronic F127 aqueous solution, it takes about 5–6 min for the fluorescence intensity to reach the maximum (or equilibrium) state (Figure S1A). The slow response might be caused by the K+-binding competition between KS6 and Pluronic F127, which has a similar [OCH2CH2] unit as KS6 does. The titration of KS6 in CTAB solution can reach equilibrium state in 10 sec after simple shaking the solution (Figure S1B), thus CTAB was selected for further experiments.

Figure 1 shows the titration result of KS6 (5.0 μM) carried out in Tris/HCl buffer (pH: 7.4, 10 mM)/CTAB (0.5 mM) with KCl concentration from 5 to 800 mM. KS6 without binding K+ has a maximum absorbance peak at 582 nm in aqueous solution and an extinction coefficient of 2.5×104 M−1cm−1 (Figure S2A). Upon binding K+ ion (0.8 M), the maximum absorbance peak blue-shifted to 567 nm with an extinction coefficient of 3.05×104 M−1cm−1. KS6 demonstrated very weak fluorescence peak at 572 nm in its free form, and a quantum yield (ϕf) as low as 0.7% using rhodamine 101 in ethanol (ϕf = 1.0) as a reference.[21] The fluorescence peak at 572 nm increased by 1.3 and 57-fold at K+ concentrations of 5 mM and 150 mM (typical extracellular and intracellular K+ concentrations), corresponding to ϕf of 1.0% and 14.4%, respectively. The excitation spectrum of KS6-K+ complex showed a maximum peak at 565 nm and a shoulder peak at 527 nm (Figure S2B). The emission spectrum of KS6-K+ complex demonstrated a maximum peak at 572 nm and a broad shoulder peak from 600 to 690 nm. Theoretical calculation of Kd using either linear Benesi-Hildebrand equation or Hill plot failed,[22] which might be caused by the high ionic strength and the presence of surfactant in the solution. From the F/F0 vs. log[K+] plot, we found that KS6 is suitable for monitoring K+ between 30 mM and 500 mM. We suggest a concentration of [K+]c (~170 mM) at ½[Fmax-F0], to be used to compare with the Kd of other K+ sensors.

Figure 1.

Figure 1

Fluorescence spectra of KS6 (5.0 μM) in Tris buffer (pH=7.4, 5 mM)/CTAB (0.50 mM) containing different concentrations of KCl, (λex: 540 nm). The inserting figure shows F/F0 at 572 nm vs. [K+]. F0 is the intensity before adding K+ ions. F is the intensity at various concentrations of K+ ions.

For fluorescent sensor with photoinduced charge transfer mechanism, the fluorescence quantum yields often decrease with the increase of the solvent polarity, which was also observed in BODIPY fluorophores.[23] To clarify the sensing mechanism of the KS6 sensor, a NaCl aqueous solution (4.0 M) was used to titrate the KS6 for comparison. Unlike titration with KCl, no UV-Vis spectra change was observed during the titration (Figure S3A). The fluorescence band in the range of 600–700 nm increased with the increase of the concentration of Na+ up to 0.80 M (Figure S3B). At a Na+ concentration of ~150 mM, which is close to the extracellular concentration of Na+, the increase of fluorescence intensity caused by the ionic strength effect can be omitted (Figure S3C), indicating that the response of KS6 is mainly due to the binding of the K+ ions, not its dispersion in less polar CTAB phase at a high ionic strength.

The fluorescence intensity of the KS6 sensor is independent of pH in the range of 5.5–9.0 (Figure 2A). It started to decrease when pH of the buffer solution decreases from 5.5 to 4.0. The pH value in mitochondria (pH: ~8) never reaches so low in a live cell, and thus it doesn’t affect its application in the mitochondria. Selectivity of KS6 was also tested against the physiological levels of the following metal ions: Na+, Ca2+, Mg2+, Fe3+, Fe2+, Zn2+, Mn2+ and Cu2+ (Figure 2B) and H2O2 (100 mM), no significant effect was observed. Therefore, KS6 demonstrated high selectivity for K+ in an ambient cell environment, and good chemical stability to H2O2, indicating its capability to monitor the concentration change of K+ in intracellular environments.

Figure 2.

Figure 2

A. Fluorescence intensities of KS6 (5 μM) in different pH Britton-Robinson buffer solution (CTAB: 0.5 mM) containing no KCl, 10 mM KCl, and 150 mM KCl, respectively. B. Fluorescence intensities of KS6 (5 μM KS6 in CTAB: 0.5 mM) containing only sensor (black), metal ions (red), both metal ions and 5 mM KCl (green), and metal ions and 150 mM KCl (blue).

The cytotoxicity of KS6 to human HeLa cells was investigated using MTT assay. At a concentration of 3 μM of KS6, more than 90% of the cells were viable after internalization of the sensor in cells for 3 h (Figure S4). While at a lower concentration of 2 μM of KS6, more than 80% of the cells were viable after 15 h. In both cases, KS6 can be used for cell imaging due to its large absorption coefficient and high fluorescent quantum yield after binding K+ ion. A colocalization assay was carried out with mitochondrial dye MitoTracker® Green FM and KS6 in the HeLa cells (Figure 3). The Pearson’s correlation coefficient and the Mander’s overlap coefficient are 0.89 and 0.94, respectively, indicating that KS6 is predominantly localized in the mitochondria of live cells.[24] Similar colocalization phenomenon was observed in U87MG cells.

Figure 3.

Figure 3

Confocal fluorescence images of KS6 (2 μM) in HeLa cells co-stained with MitoTracker® Green FM. (A) red emission from KS6; (B) green emission from MitoTracker® Green; (C) overlay of MitoTracker Green, KS6 and bright-field images.

To monitor the mitochondrial K+ concentration change under stimulation, HeLa cells internalized with KS6 (2 μM) for 10 min were treated with an ionophore, ionomycin (10 μM) at 37 °C. Fast efflux of mitochondrial K+ within 2 min was observed by the decrease of fluorescence intensity (Figure 4). Control experiments without ionomycin stimulation showed no obvious fluorescence intensity change in culture medium containing either 20 or 200 mM KCl, respectively (Figure S5A and S5B).

Figure 4.

Figure 4

Time-dependent fluorescence images of KS6-stained HeLa cells stimulated by ionomycin observed under confocal fluorescence microscope: t = 0 (before the addition of ionomycin); t = 0.75, 1, 2, 10 min, respectively, after adding ionomycin (20 μM final concentration) into the culture medium containing 20 mM of KCl. Average fluorescence intensity ratios as measured by Image J. F0 is the average fluorescence intensity at t=0 min; F is the average fluorescence intensity at given times.

The influx and then efflux of K+ in mitochondria was observed in HeLa cells after stimulation with another ionophore, nigericin (10 μM), in a medium containing 200 mM of KCl (Figure S6). Within 30 sec, the average fluorescent intensity of cells increased by 60%, indicating the influx of K+ in mitochondria. After 2 min, potassium efflux from mitochondria was observed by the decrease of fluorescence intensity. The final intensity after stabilization for 10 min was 40% above that before stimulation by nigericin.

U87MG, a glial cell phenotype, can physiologically act as a K+ buffer to remove excess potassium.[25] Different from HeLa cells, simple treatment of U87MG cells with a medium containing 20 mM of KCl caused slow fluorescence intensity decrease to 74% in 12 min. When the concentration of KCl in the medium increased to 200 mM, the fluorescence intensity from U87MG cells first jumped 50% above that before the treatment, and slowly decreased to its original state (Figure S7). Stimulating U87MG cells with ionomycin (10 μM) in medium caused a fluorescence intensity decrease to 59% from mitochondria within 2 min, and finally reached 30% of its original intensity in the end, indicating the K+ efflux from the mitochondria (Figure S8).

K+ influx/efflux was also observed when KS6 internalized U87MG cells were treated with nigericin (20 μM) in the presence of 200 mM of KCl. Within 30 sec, the fluorescence intensity of U87MG cells increased by 250% (Figure 5). After reaching the fluorescence maximum, the fluorescence intensity started to decrease and decayed to 75% of the maximum value, indicating the efflux of K+ ions from mitochondria. The quick influx of the K+ ions in mitochondria might be caused by nigericin-facilitated diffusion of K+ ions into the mitochondrial under transmembrane potential.

Figure 5.

Figure 5

Time-dependent fluorescence images of KS6-stained U87MG cells stimulated by nigericin observed under confocal fluorescence microscope: t = 0 (before the addition of nigericin); t = 0.5, 1, 5, 15 min, respectively, after adding nigericin (20 μM final concentration) into the culture medium containing 200 mM of KCl.

Carbonyl cyanide m-chlorophenylhydrazone (CCCP), one of OXPHOS uncouplers working as proton transmembrane carrier,[26] is used as a typical stimulator to study the mitochondria K+ ionic fluxes.[27]. Both HeLa and U87MG cell lines were used to dynamically detect the potassium fluxes in mitochondrial matrix in response to membrane potential changes induced by CCCP. Cells incubated with 1 μM of KS6 for 30 min were treated with different concentrations of CCCP (0, 10 μM and 40 μM). No fluorescence intensity change was observed without the CCCP treatment; whereas fluorescence intensities of KS6 in mitochondria dropped about 50% in U87MG cells and 20% in HeLa cells depending on CCCP concentrations, showing the different behaviors of various cell lines (Figure S9 and S10) to the stimulation.

In summary, we have developed KS6, a predominantly mitochondria-targeting K+ sensor, that selectively responds to K+ with a 130-fold florescence enhancement, (at a K+ concentration of 0.8 M) and a dynamic K+ ion concentration range (30–500 mM). The presence of triphenylphosphonium group in KS6 enables its localization in the mitochondria, making it the first mitochondria-specific K+ sensor. By using this sensor, we have demonstrated that KS6 is a useful tool to monitor mitochondria potassium fluxes (both influx and efflux) under various stimulations, although not quantitatively yet. We believe that KS6 has potential applications in investigating many biological processes, especially in single cell analysis, cancer studies, insulin secretion, inflammatory response, drug screening, and cellular apoptosis.

Experimental Section

Synthesis, characterization, and experimental details are available in the Supporting information.

Supplementary Material

Supporting Information

Footnotes

**

This work was supported by the NIH National Human Genome Research Institute, Centers of Excellence in Genomic Science, grant number 5 P50 HG002360, and the NIH Common Fund LINCS program, grant number 5 U01 CA164250 (Professor Deirdre R. Meldrum, PI). We would like to thank Dr. Honor Glenn and Dr. Kimberly Bussey for useful discussions

Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/anie.2015*****.

Contributor Information

Prof. Dr. Yanqing Tian, Email: yanqing.tian@asu.edu.

Prof. Dr. Deirdre R. Meldrum, Email: deirdre.meldrum@asu.edu.

References

  • 1.Miller C. Genome biology. 2000;1:REVIEWS0004. doi: 10.1186/gb-2000-1-4-reviews0004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.a) Urrego D, Tomczak AP, Zahed F, Stuhmer W, Pardo LA. Philos Trans R Soc Lond, Ser B: Biol Sci. 2014;369:20130094. doi: 10.1098/rstb.2013.0094. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Szabo I, Leanza L, Gulbins E, Zoratti M. Pfluegers Arch Eur J Physiol. 2012;463:231–246. doi: 10.1007/s00424-011-1058-7. [DOI] [PubMed] [Google Scholar]; c) Malinska D, Mirandola SR, Kunz WS. FEBS Lett. 2010;584:2043–2048. doi: 10.1016/j.febslet.2010.01.013. [DOI] [PubMed] [Google Scholar]; d) Petrilli V, Papin S, Dostert C, Mayor A, Martinon F, Tschopp J. Cell Death Differ. 2007;14:1583–1589. doi: 10.1038/sj.cdd.4402195. [DOI] [PubMed] [Google Scholar]
  • 3.a) Levin M, Stevenson CG. Annu Rev Biomed Eng. 2012;14:295–323. doi: 10.1146/annurev-bioeng-071811-150114. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Wang ZW, Saifee O, Nonet ML, Salkoff L. Neuron. 2001;32:867–881. doi: 10.1016/s0896-6273(01)00522-0. [DOI] [PubMed] [Google Scholar]
  • 4.a) Huang X, Jan LY. J Cell Biol. 2014;206:151–162. doi: 10.1083/jcb.201404136. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Wulff H, Zhorov BS. Chem Rev. 2008;108:1744–1773. doi: 10.1021/cr078234p. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Mattson MP, Kroemer G. Trends Mol Med. 2003;9:196–205. doi: 10.1016/s1471-4914(03)00046-7. [DOI] [PubMed] [Google Scholar]; d) Rorsman P, Braun M. Annu Rev Physiol. 2013;75:155–179. doi: 10.1146/annurev-physiol-030212-183754. [DOI] [PubMed] [Google Scholar]
  • 5.McManus OB. Curr Opin Pharmacol. 2014;15:91–96. doi: 10.1016/j.coph.2014.01.004. [DOI] [PubMed] [Google Scholar]
  • 6.a) Beacham DW, Blackmer T, O’Grady M, Hanson GT. J Biomol Screen. 2010;15:441–446. doi: 10.1177/1087057109359807. [DOI] [PubMed] [Google Scholar]; b) Wojtovich AP, Williams DM, Karcz MK, Lopes CMB, Gray DA, Nehrke KW, Brookes PS. Circul Res. 2010;106:1190–U1138. doi: 10.1161/CIRCRESAHA.109.215400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Rezazadeh S, Hesketh JC, Fedida D. J Biomol Screen. 2004;9:588–597. doi: 10.1177/1087057104264798. [DOI] [PubMed] [Google Scholar]
  • 8.Munoz-Planillo R, Kuffa P, Martinez-Colon G, Smith BL, Rajendiran TM, Nunez G. Immunity. 2013;38:1142–1153. doi: 10.1016/j.immuni.2013.05.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Xu JC, Wang PL, Li YY, Li GY, Kaczmarek LK, Wu YL, Koni PA, Flavell RA, Desir GV. Proc Natl Acad Sci USA. 2004;101:3112–3117. doi: 10.1073/pnas.0308450100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Jackson DG, Wang JJ, Keane RW, Scemes E, Dahl G. Scientific Reports. 2014;4:srep04576. doi: 10.1038/srep04576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R, Lee CT, Lopaschuk GD, Puttagunta L, Bonnet S, Harry G, Hashimoto K, Porter CJ, Andrade MA, Thebaud B, Michelakis ED. Cancer Cell. 2007;11:37–51. doi: 10.1016/j.ccr.2006.10.020. [DOI] [PubMed] [Google Scholar]
  • 12.Lidstrom ME, Meldrum DR. Nat Rev Microbiol. 2003;1:158–164. doi: 10.1038/nrmicro755. [DOI] [PubMed] [Google Scholar]
  • 13.Nolin F, Michel J, Wortham L, Tchelidze P, Balossier G, Banchet V, Bobichon H, Lalun N, Terryn C, Ploton D. Cell Mol Life Sci. 2013;70:2383–2394. doi: 10.1007/s00018-013-1267-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Alberts B. Essential cell biology. 3. Garland Science; New York: 2010. [Google Scholar]
  • 15.a) Minta A, Tsien RY. J Biol Chem. 1989;264:19449–19457. [PubMed] [Google Scholar]; b) Szmacinski H, Lakowicz JR. Sens Actuators, B: Chem. 1999;60:8–18. doi: 10.1016/s0925-4005(99)00235-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.He H, Mortellaro MA, Leiner MJP, Fraatz RJ, Tusa JK. J Am Chem Soc. 2003;125:1468–1469. doi: 10.1021/ja0284761. [DOI] [PubMed] [Google Scholar]
  • 17.a) Namkung W, Padmawar P, Mills AD, Verkman AS. J Am Chem Soc. 2008;130:7794. doi: 10.1021/ja8014499. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Carpenter RD, Verkman AS. Eur J Org Chem. 2011:1242–1248. doi: 10.1002/ejoc.201001450. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Padmawar P, Yao XM, Bloch O, Manley GT, Verkman AS. Nat Methods. 2005;2:825–827. doi: 10.1038/nmeth801. [DOI] [PubMed] [Google Scholar]; d) Carpenter RD, Verkman AS. Org Lett. 2010;12:1160–1163. doi: 10.1021/ol902836c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.a) Zhou XF, Su FY, Gao WM, Tian YQ, Youngbull C, Johnson RH, Meldrum DR. Biomaterials. 2011;32:8574–8583. doi: 10.1016/j.biomaterials.2011.07.081. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Zhou XF, Su FY, Tian YQ, Youngbull C, Johnson RH, Meldrum DR. J Am Chem Soc. 2011;133:18530–18533. doi: 10.1021/ja207345s. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hirata T, Terai T, Komatsu T, Hanaoka K, Nagano T. Bioorg Med Chem Lett. 2011;21:6090–6093. doi: 10.1016/j.bmcl.2011.08.056. [DOI] [PubMed] [Google Scholar]
  • 20.a) Ross MF, Kelso GF, Blaikie FH, James AM, Cocheme HM, Filipovska A, Da Ros T, Hurd TR, Smith RAJ, Murphy MP. Biochemistry-Moscow. 2005;70:222–230. doi: 10.1007/s10541-005-0104-5. [DOI] [PubMed] [Google Scholar]; b) Hu QL, Gao M, Feng GX, Liu B. Angew Chem Int Ed. 2014;53:14225–14229. doi: 10.1002/anie.201408897. [DOI] [PubMed] [Google Scholar]; c) Krumova K, Greene LE, Cosa G. J Am Chem Soc. 2013;135:17135–17143. doi: 10.1021/ja408227f. [DOI] [PubMed] [Google Scholar]; d) Leung CWT, Hong YN, Chen SJ, Zhao EG, Lam JWY, Tang BZ. J Am Chem Soc. 2013;135:62–65. doi: 10.1021/ja310324q. [DOI] [PubMed] [Google Scholar]
  • 21.Karstens T, Kobs K. J Phys Chem. 1980;84:1871–1872. [Google Scholar]
  • 22.Boens N, Leen V, Dehaen W. Chem Soc Rev. 2012;41:1130–1172. doi: 10.1039/c1cs15132k. [DOI] [PubMed] [Google Scholar]
  • 23.a) Rurack K, Kollmannsberger M, Daub J. Angew Chem Int Ed. 2001;40:385–387. [PubMed] [Google Scholar]; b) Baruah M, Qin WW, Flors C, Hofkens J, Vallee RAL, Beljonne D, Van der Auweraer M, De Borggraeve WM, Boens N. J Phys Chem A. 2006;110:5998–6009. doi: 10.1021/jp054878u. [DOI] [PubMed] [Google Scholar]
  • 24.Dunn KW, Kamocka MM, McDonald JH. Am J Physiol Cell Physiol. 2011;300:C723–C742. doi: 10.1152/ajpcell.00462.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Kofuji P, Newman EA. Neuroscience. 2004;129:1045–1056. doi: 10.1016/j.neuroscience.2004.06.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Hopfer U, Lehninge Al, Thompson TE. Proc Natl Acad Sci USA. 1968;59:484. doi: 10.1073/pnas.59.2.484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.a) Garlid KD, Paucek P. Bba-Bioenergetics. 2003;1606:23–41. doi: 10.1016/s0005-2728(03)00108-7. [DOI] [PubMed] [Google Scholar]; b) Chalmers S, McCarron JG. J Cell Sci. 2008;121:75–85. doi: 10.1242/jcs.014522. [DOI] [PubMed] [Google Scholar]; c) Perry SW, Norman JP, Barbieri J, Brown EB, Gelbard HA. BioTechniques. 2011;50:98. doi: 10.2144/000113610. [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Szabo I, Zoratti M. Physiol Rev. 2014;94:519–608. doi: 10.1152/physrev.00021.2013. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES